Are you above the legal age to view this content in your province/state?

Home / Industry News / Study Finds Marijuana Use Not Linked to Increased Stroke Risk

Study Finds Marijuana Use Not Linked to Increased Stroke Risk

U.S., June 3, 2020 (HCPLive)- Contradicting the results of many previous studies, a recent analysis from a team of neurologists at the University of Mississippi Medical Center found no link between marijuana use and increased stroke risk.

While observational in nature, results of the analysis, which included nearly 10k people, add to the ongoing discussion surrounding the apparent risks and benefits as the prevalence of marijuana use continues to grow.

“Previous studies that investigated cannabis use and risk of stroke have had conflicting results, some showing a decreased risk and others showing a greatly increased risk,” said lead investigator Carmela San Luis, MD, of the University of Mississippi in Jackson and a member of the American Academy of Neurology (AAN), in a statement from the AAN. “Our observational study looked specifically at recent cannabis use by reviewing drug testing data for people admitted to the hospital. While more research is needed with larger numbers of people, our study lends support to the studies showing that cannabis use does not increase the risk of stroke.”

With a multitude of studies and analyses producing conflicting conclusions on the impact of marijuana use on stroke risk, San Luis and a team of colleagues designed the current study to assess potential correlations between recent marijuana use—defined as a positive cannabinoid urine drug screen on admission—and diagnosis of acute ischemic stroke.  Using a de-identified hospital database, the retrospective observational study included 9350 patients from University of Mississippi Medical Center admitted from 2015-2017—of the 9350 patients 18% tested positive for cannabis use.

Ischemic stroke among these patients was identified through ICD-10 codes and use of marijuana was confirmed through a positive urine drug screen. Of note, those who also tested positive amphetamines or cocaine and those with diagnoses of hemorrhagic stroke and transient ischemic attack were excluded from the analysis.

From the database, investigators obtained information related to age, race/ethnicity, sickle cell disease, family history of stroke, dyslipidemia, hypertension status, obesity, diabetes mellitus, cigarette smoking, atrial fibrillation, other cardiac conditions, and carotid artery stenosis, which were included as confounders in the investigators’ multivariate logistic regression analysis.

Analysis indicated the cohort of cannabis users had a greater prevalence of males (67.82% vs 50.98%), younger patients (mean age 38±14 vs 50±18), current cigarette smokers (63.22% vs 33.61%), and African Americans (72.15% vs 56.68%) than the cohort of nonusers (P <.001). Investigators noted rates of AF/atrial flutter (4.11% vs 1.22%), hypertension (21.21% vs 13.15%), dyslipidemia (6.11% vs 2.5%), personal history of stroke (2.34% vs 0.97%), diabetes mellitus (12.48% vs 4.81%), and other cardiac disease (7.24% vs 3.71%) were greater among those who tested negative for cannabis use (P <.001).

Prevalence of family history of stroke (0 vs 1; P=.03) and obesity (2.05% vs 1.10%; P=.010) were also greater among patients who tested negative for cannabis use.

Overall, ischemic stroke was observed in 130 (7.91%) of 1643 subjects who tested positive for cannabis use and in 1207 (15.66%) of the 7707 subjects who tested negative. Upon adjustment for confounding factors, the apparent decrease in risk was lost.

“Our research adds to the list of studies with conflicting results, so it is important to continue to investigate stroke risk and cannabis use,” said San Luis, in the aforementioned statement. “Future studies are now needed in larger groups of people that not only include data from drug screenings but also dosing amounts as well as a person’s history of cannabis use.”

Investigators stressed the importance of considering the observational nature of their analysis when interpreting results. Investigators also pointed out their study was unable to account for information related to synthetic cannabis use and for certain risk factors, such as physical activity and BMI.

This study, “Association Between Recent Cannabinoid Use and Acute Ischemic Stroke,” was published in Neurology.


Investment Value Finders specializes in providing opinions and information on stocks to individuals who wish to receive them. Our reports are construed for information purposes solely and are distributed free of charge to individuals who wish to receive them.

Investment Value Finders does not promote, condone or advocate licit or illicit drug use. Investment Value Finders cannot be held responsible for materials or contests posted on its website pages, or pages to which we provide links, which promote, condone or advocate licit or illicit drug use or illegal activities.

DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS WEBSITE. We are not registered as a securities broker-dealer or an investment adviser. We are neither licensed nor qualified to provide investment advice.

Investment Value Finders occasionally receives direct compensation for hosting links (or other* advertisements) to third party content that may be subject to disclaimer pursuant to Section 17(b) of the Securities Act of 1933. For those instances where the link text contains company or stock-specific mention, we provide the following list of compensation received in order to ensure full disclosure and transparency.

Investment Value Finders is intended for those 21+ years of age only!

Check Also

Stocks and Founds that are overexposed To Russia And Ukraine

Stock markets worldwide have been in red since Russia began its invasion of Ukraine last …